Hair Diseases clinical trials at University of California Health
1 in progress, 0 open to eligible people
Sorry, not currently recruiting here
The main purpose of this study is to determine the efficacy and safety of baricitinib for the treatment of severe or very severe alopecia areata (hair loss) in children from 6 years to less than 18 years of age. The study is divided into 4 periods, a 5-week Screening period, a 36-week Double-Blind Treatment Period, an approximately 2-year Long-term Extension Period, and a 4-week Post-treatment Follow-up period.
Our lead scientists for Hair Diseases research studies include Dawn Eichenfield.